Sign in
8-K

Current Report

Moleculin Biotech, Inc. Filed Acc 0001437749-23-024329

Bylaws or fiscal year change

  • Item 5.03 Amendments to articles or bylaws; change in fiscal year

From the SEC's structured data for this filing

Loading mbrx20230821_8k.htm…